Systems Biology Analysis of the Lung Cancer‑Related Secretome

Total Page:16

File Type:pdf, Size:1020Kb

Systems Biology Analysis of the Lung Cancer‑Related Secretome ONCOLOGY REPORTS 40: 1103-1118, 2018 Systems biology analysis of the lung cancer‑related secretome LIN FENG1*, YIKUN YANG2*, MIN LI1, JIE SONG1, YANNING GAO1, SHUJUN CHENG1 and TING XIAO1 1State Key Laboratory of Molecular Oncology, Beijing Key Laboratory for Carcinogenesis and Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; 2Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China Received September 14, 2017; Accepted May 18, 2018 DOI: 10.3892/or.2018.6509 Abstract. Tumorigenesis is closely and highly associated with full-term placenta after delivery. ELISA results demonstrated developmental biology. The present study aimed to discover that hypoxanthine phosphoribosyltransferase 1 (HPRT1) and identify marker proteins strongly associated with the was associated with worse rates of disease-free survival occurrence and development of non-small cell lung cancer (DFS) and overall survival (OS). The biological behaviors of (NSCLC) in humans and to provide new ideas for investi- embryonic implantation are similar to those of tumor inva- gating lung cancer markers by combining biological analyses sion and metastasis, and the information obtained regarding of embryonic development. We established primary cultures developmental biology could facilitate the interpretation of for samples of tumor and control tissues from 9 patients tumor invasion and metastasis. Therefore, similar biological with NSCLC and collected conditioned medium (CM). behaviors combined with analyses at different molecular Subsequently, we used liquid chromatography and linear ion levels from the perspective of systems biology will provide trap (LTQ) mass spectrometry to isolate and identify proteins new ideas for tumor research. in CM samples. Data mining of free proteins was conducted using the analogous analysis strategy in systems biology to Introduction obtain important lung cancer-associated proteins (plasma markers). Proteins with significant plasma enrichment in lung Lung cancer is also known as primary bronchogenic carcinoma cancer patients were detected via enzyme-linked immuno- and is a type of malignancy that originates in the bronchial sorbent assay (ELISA). We identified 987 high‑confidence epithelium. Lung cancer is one of the most common malignant proteins and established a primary database of free proteins tumors and the most deadly cancer worldwide (1). In recent associated with lung cancer. Furthermore, 511 high‑confi- years, due to population aging, smoking, environmental pollu- dence proteins were present in CM from primary tissue tion and other factors, the incidence and mortality rates of lung cultures from at least 2 of the 9 examined cases of lung cancer. cancer have tended to increase across the globe, especially in Analysis using Gene Set Enrichment Analysis (GSEA) soft- China and other developing countries (2). Biomarkers are of ware revealed significant enrichment for 197 proteins from great significance for the diagnosis and treatment of diseases, the CM of lung cancer samples in maternal-placental inter- particularly cancers. With the development of large-scale face expression profiles for a mid‑term placenta with strong proteomic technology, especially biological mass spectrom- invasiveness relative to RNA expression profiles for a human etry (MS), proteomic technology has become a mainstream technological approach in cancer biomarker discovery. Embryos and tumors share great similarities in many respects. In 1829, French scientists, Lobstein and Recamier, first proposed the concept of an embryonic origin of tumors, Correspondence to: Professor Ting Xiao, State Key Laboratory that is, cancer occurs due to the continued proliferation of of Molecular Oncology, Beijing Key Laboratory for Carcinogenesis embryonic cells present in the body (3). In the 1970s, Pierce and Cancer Prevention, National Cancer Center/National Clinical developed the theory of ‘cancer, a problem of developmental Research Center for Cancer/Cancer Hospital, Chinese Academy biology’ and noted that tumorigenesis is closely and strongly of Medical Sciences and Peking Union Medical College, related to developmental biology (4). Due to the similarity 17 Panjiayuannanli, Chaoyang, Beijing 100021, P.R. China E-mail: [email protected] between tumors and embryonic cells during gestation in terms of growth, invasion and immune system suppression, it has *Contributed equally been proposed in recent years that we should think of and study tumors from an evolutionary perspective (5‑7). With Key words: lung cancer, conditioned medium, embryonic development, the development of experimental techniques and the increase systems biology, hypoxanthine phosphoribosyltransferase 1 in research investigations, the early hypothesis that embry- onic development and tumorigenesis are closely related has increasingly been confirmed. 1104 FENG et al: SYSTEMIC ANALYSIS OF EXOSOME PROTEINS IN LUNG CANCER In our preliminary study, to eliminate the interference Supernatants were collected, divided into aliquots and stored of high-abundance proteins in the blood and enrich lung at ‑80˚C until use. Disease‑free survival (DFS) was defined as cancer‑specific markers in body fluid, we established a new the interval between surgery and recurrence; if recurrence was primary organ culture model to detect the free proteins released not diagnosed, the date of death or last follow-up was recorded. by tumor cells into the bloodstream (8). In the present study, Overall survival (OS) was defined as the interval between we used the research system for tumor-associated proteins in surgery and death. After surgery, patients were followed up body fluid that was established in our preliminary study. We for over eight years or until death. At the end of the follow-up also established primary cultures of tumor and control tissue period (11‑99 months, with a mean of 74 months), tumor recur- samples from non-small cell lung cancer (NSCLC) patients rence had been identified in 33 (55.0%) patients; 27 (45.0%) and collected conditioned medium (CM). We then used patients had died at the time of data censorship. liquid chromatography (LC) and linear ion trap (LTQ) MS to isolate and identify the full spectrum of the total proteins Primary tissue culture and CM collection. We chose different in CM samples. Subsequently, we used BRB-ArrayTools control tissues depending on pathological characteristics. For (http://linus.nci.nih.gov/BRB-ArrayTools.html), ArraySVG SCC, the control tissue was normal bronchial tissue from the and other programs and analyzed MS data using the spectral same patient. For ADC and large cell lung cancer (LCLC), the counts produced by label-free quantitative proteomics as the control tissue was normal lung tissue from the same patient. In quantitative parameter. We used the Gene Set Enrichment all cases, the distance between the control and tumor tissues Analysis P (GSEA-P) program to conduct enrichment analysis was >3 cm. Samples of paracancerous bronchial/lung tissues of the free proteins identified in tumor tissue CM based on and lung cancer tissues that were dissected from the body the maternal-placental interface expression profile data at within 30 min were cut into small pieces with volumes of different stages. Data mining of free proteins was conducted approximately 5 mm3 using a scalpel. Tissue pieces were placed to identify important lung cancer-associated plasma proteins. into collagen-coated gridded dishes, and LHC-9 medium (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, Materials and methods USA) was added carefully and slowly in a dropwise manner to prevent disruption of these pieces. The dishes were placed Sample collection. Tissue samples of lung cancer patients for in a culture box, which was then filled with a gas mixture of the present study were all taken from hospitalized patients in 50% N2, 45% O2 and 5% CO2. The culture box was placed the Department of Thoracic Surgery at the Cancer Hospital of on a shaker, with a shaking frequency of 8-10 times/min. the Chinese Academy of Medical Sciences and Peking Union CM was collected after 24 h of incubation in a 36.5˚C incu- Medical College. When the specimens were obtained, none bator. The collected CM was added to an Amicon Ultra tube of the patients had received physical or chemical treatments. (cat no. UFC900596; Millipore; Merck KGaA, Darmstadt, We conducted a comprehensive collection of patient clinical Germany) and then centrifuged for 45 min at 4,000 x g and data. The histopathological types of surgically resected 4˚C. This process was performed to desalinate and concentrate tumor tissues were determined by senior pathologists based the sample. on the World Health Organization (WHO) classification of lung cancer tissue. Tumor staging was determined based on LC‑MS analysis and identification of proteins released into the 7th edition of the Union for International Cancer Control CM by cells (UICC) tumor-node-metastasis (TNM) staging system. Enzyme digestion of proteins in CM. A total of 30 µg of CM During the period from September 2005 to October 2006, we proteins was dissolved in 50 µl of solution containing 8 M urea collected fresh tumor and control tissue samples for primary and 10 mM dithiothreitol (DTT); 100 µl of 50 mM NH4HCO3 culture
Recommended publications
  • ACTR2 Antibody / Arp2 (RQ5865)
    ACTR2 Antibody / Arp2 (RQ5865) Catalog No. Formulation Size RQ5865 0.5mg/ml if reconstituted with 0.2ml sterile DI water 100 ug Bulk quote request Availability 1-3 business days Species Reactivity Human, Mouse, Rat, Monkey Format Antigen affinity purified Clonality Polyclonal (rabbit origin) Isotype Rabbit IgG Purity Affinity purified Buffer Lyophilized from 1X PBS with 2% Trehalose and 0.025% sodium azide UniProt P61160 Applications Western blot : 0.5-1ug/ml Immunohistochemistry : 1-2ug/ml Immunofluorescence : 2-4ug/ml Flow cytometry : 1-3ug/million cells Direct ELISA : 0.1-0.5ug/ml Limitations This ACTR2 antibody is available for research use only. IHC staining of FFPE human breast cancer with ACTR2 antibody. HIER: boil tissue sections in pH8 EDTA for 20 min and allow to cool before testing. Immunofluorescent staining of FFPE human A549 cells with ACTR2 antibody (green) and DAPI nuclear stain (blue). HIER: steam section in pH6 citrate buffer for 20 min. Western blot testing of 1) rat kidney, 2) rat spleen, 3) mouse HEPA1-6, 4) mouse SP2/0, 5) monkey COS-7 and human 6) U-87 MG, 7) Jurkat, 8) PC-3 and 9) U-2 OS lysate with ACTR2 antibody. Predicted molecular weight ~45 kDa. Flow cytometry testing of human A431 cells with ACTR2 antibody at 1ug/million cells (blocked with goat sera); Red=cells alone, Green=isotype control, Blue= ACTR2 antibody. Flow cytometry testing of mouse ANA-1 cells with ACTR2 antibody at 1ug/million cells (blocked with goat sera); Red=cells alone, Green=isotype control, Blue= ACTR2 antibody. Description The specific function of this gene has not yet been determined; however, the protein it encodes is known to be a major constituent of the ARP2/3 complex.
    [Show full text]
  • Implications in Parkinson's Disease
    Journal of Clinical Medicine Review Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson’s Disease Silvia Paciotti 1,2 , Elisabetta Albi 3 , Lucilla Parnetti 1 and Tommaso Beccari 3,* 1 Laboratory of Clinical Neurochemistry, Department of Medicine, University of Perugia, Sant’Andrea delle Fratte, 06132 Perugia, Italy; [email protected] (S.P.); [email protected] (L.P.) 2 Section of Physiology and Biochemistry, Department of Experimental Medicine, University of Perugia, Sant’Andrea delle Fratte, 06132 Perugia, Italy 3 Department of Pharmaceutical Sciences, University of Perugia, Via Fabretti, 06123 Perugia, Italy; [email protected] * Correspondence: [email protected] Received: 29 January 2020; Accepted: 20 February 2020; Published: 21 February 2020 Abstract: Ceramides are a family of bioactive lipids belonging to the class of sphingolipids. Sphingolipidoses are a group of inherited genetic diseases characterized by the unmetabolized sphingolipids and the consequent reduction of ceramide pool in lysosomes. Sphingolipidoses include several disorders as Sandhoff disease, Fabry disease, Gaucher disease, metachromatic leukodystrophy, Krabbe disease, Niemann Pick disease, Farber disease, and GM2 gangliosidosis. In sphingolipidosis, lysosomal lipid storage occurs in both the central nervous system and visceral tissues, and central nervous system pathology is a common hallmark for all of them. Parkinson’s disease, the most common neurodegenerative movement disorder, is characterized by the accumulation and aggregation of misfolded α-synuclein that seem associated to some lysosomal disorders, in particular Gaucher disease. This review provides evidence into the role of ceramide metabolism in the pathophysiology of lysosomes, highlighting the more recent findings on its involvement in Parkinson’s disease. Keywords: ceramide metabolism; Parkinson’s disease; α-synuclein; GBA; GLA; HEX A-B; GALC; ASAH1; SMPD1; ARSA * Correspondence [email protected] 1.
    [Show full text]
  • Propranolol-Mediated Attenuation of MMP-9 Excretion in Infants with Hemangiomas
    Supplementary Online Content Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4773 eTable. List of All of the Proteins Identified by Proteomics This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable. List of All of the Proteins Identified by Proteomics Protein Name Prop 12 mo/4 Pred 12 mo/4 Δ Prop to Pred mo mo Myeloperoxidase OS=Homo sapiens GN=MPO 26.00 143.00 ‐117.00 Lactotransferrin OS=Homo sapiens GN=LTF 114.00 205.50 ‐91.50 Matrix metalloproteinase‐9 OS=Homo sapiens GN=MMP9 5.00 36.00 ‐31.00 Neutrophil elastase OS=Homo sapiens GN=ELANE 24.00 48.00 ‐24.00 Bleomycin hydrolase OS=Homo sapiens GN=BLMH 3.00 25.00 ‐22.00 CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 4.00 26.00 ‐22.00 S10A8_HUMAN Protein S100‐A8 OS=Homo sapiens GN=S100A8 PE=1 14.67 30.50 ‐15.83 SV=1 IL1F9_HUMAN Interleukin‐1 family member 9 OS=Homo sapiens 1.00 15.00 ‐14.00 GN=IL1F9 PE=1 SV=1 MUC5B_HUMAN Mucin‐5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 2.00 14.00 ‐12.00 MUC4_HUMAN Mucin‐4 OS=Homo sapiens GN=MUC4 PE=1 SV=3 1.00 12.00 ‐11.00 HRG_HUMAN Histidine‐rich glycoprotein OS=Homo sapiens GN=HRG 1.00 12.00 ‐11.00 PE=1 SV=1 TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 17.00 28.00 ‐11.00 CATG_HUMAN Cathepsin G OS=Homo
    [Show full text]
  • Protein Interaction Network of Alternatively Spliced Isoforms from Brain Links Genetic Risk Factors for Autism
    ARTICLE Received 24 Aug 2013 | Accepted 14 Mar 2014 | Published 11 Apr 2014 DOI: 10.1038/ncomms4650 OPEN Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism Roser Corominas1,*, Xinping Yang2,3,*, Guan Ning Lin1,*, Shuli Kang1,*, Yun Shen2,3, Lila Ghamsari2,3,w, Martin Broly2,3, Maria Rodriguez2,3, Stanley Tam2,3, Shelly A. Trigg2,3,w, Changyu Fan2,3, Song Yi2,3, Murat Tasan4, Irma Lemmens5, Xingyan Kuang6, Nan Zhao6, Dheeraj Malhotra7, Jacob J. Michaelson7,w, Vladimir Vacic8, Michael A. Calderwood2,3, Frederick P. Roth2,3,4, Jan Tavernier5, Steve Horvath9, Kourosh Salehi-Ashtiani2,3,w, Dmitry Korkin6, Jonathan Sebat7, David E. Hill2,3, Tong Hao2,3, Marc Vidal2,3 & Lilia M. Iakoucheva1 Increased risk for autism spectrum disorders (ASD) is attributed to hundreds of genetic loci. The convergence of ASD variants have been investigated using various approaches, including protein interactions extracted from the published literature. However, these datasets are frequently incomplete, carry biases and are limited to interactions of a single splicing isoform, which may not be expressed in the disease-relevant tissue. Here we introduce a new interactome mapping approach by experimentally identifying interactions between brain-expressed alternatively spliced variants of ASD risk factors. The Autism Spliceform Interaction Network reveals that almost half of the detected interactions and about 30% of the newly identified interacting partners represent contribution from splicing variants, emphasizing the importance of isoform networks. Isoform interactions greatly contribute to establishing direct physical connections between proteins from the de novo autism CNVs. Our findings demonstrate the critical role of spliceform networks for translating genetic knowledge into a better understanding of human diseases.
    [Show full text]
  • Large-Scale Serum Protein Biomarker Discovery in Duchenne Muscular Dystrophy
    Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy Yetrib Hathouta, Edward Brodyb, Paula R. Clemensc,d, Linda Cripee, Robert Kirk DeLisleb, Pat Furlongf, Heather Gordish- Dressmana, Lauren Hachea, Erik Henricsong, Eric P. Hoffmana, Yvonne Monique Kobayashih, Angela Lortsi, Jean K. Mahj, Craig McDonaldg, Bob Mehlerb, Sally Nelsonk, Malti Nikradb, Britta Singerb, Fintan Steeleb, David Sterlingb, H. Lee Sweeneyl, Steve Williamsb, and Larry Goldb,1 aResearch Center for Genetic Medicine, Children’s National Medical Center, Washington, DC 20012; bSomaLogic, Inc., Boulder, CO 80301; cNeurology Service, Department of Veteran Affairs Medical Center, Pittsburgh, PA 15240; dUniversity of Pittsburgh, Pittsburgh, PA 15213; eThe Heart Center, Nationwide Children’s Hospital, The Ohio State University, Columbus, OH 15213; fParent Project Muscular Dystrophy, Hackensack, NJ 07601; gDepartment of Physical Medicine and Rehabilitation, University of California Davis School of Medicine, Davis, CA 95618; hDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202; iThe Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229; jDepartment of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, AB, Canada T3B 6A8; kDivision of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO 80045; and lDepartment of Pharmacology & Therapeutics, University of Florida College of Medicine, Gainesville, FL 32610 Contributed
    [Show full text]
  • Annexin A7 Is Required for ESCRT III-Mediated Plasma Membrane Repair
    Annexin A7 is required for ESCRT III-mediated plasma membrane repair Sønder, Stine Lauritzen; Boye, Theresa Louise; Tölle, Regine; Dengjel, Jörn; Maeda, Kenji; Jäättelä, Marja; Simonsen, Adam Cohen; Jaiswal, Jyoti K.; Nylandsted, Jesper Published in: Scientific Reports DOI: 10.1038/s41598-019-43143-4 Publication date: 2019 Document version Publisher's PDF, also known as Version of record Document license: CC BY Citation for published version (APA): Sønder, S. L., Boye, T. L., Tölle, R., Dengjel, J., Maeda, K., Jäättelä, M., ... Nylandsted, J. (2019). Annexin A7 is required for ESCRT III-mediated plasma membrane repair. Scientific Reports, 9(1), [6726]. https://doi.org/10.1038/s41598-019-43143-4 Download date: 09. apr.. 2020 www.nature.com/scientificreports OPEN Annexin A7 is required for ESCRT III-mediated plasma membrane repair Received: 16 November 2018 Stine Lauritzen Sønder1, Theresa Louise Boye1, Regine Tölle2,3, Jörn Dengjel 2,3, Accepted: 15 April 2019 Kenji Maeda1, Marja Jäättelä 1,4, Adam Cohen Simonsen 5, Jyoti K. Jaiswal 6,7 & Published: xx xx xxxx Jesper Nylandsted 1,4 The plasma membrane of eukaryotic cells forms the essential barrier to the extracellular environment, and thus plasma membrane disruptions pose a fatal threat to cells. Here, using invasive breast cancer cells we show that the Ca2+ - and phospholipid-binding protein annexin A7 is part of the plasma membrane repair response by enabling assembly of the endosomal sorting complex required for transport (ESCRT) III. Following injury to the plasma membrane and Ca2+ fux into the cytoplasm, annexin A7 forms a complex with apoptosis linked gene-2 (ALG-2) to facilitate proper recruitment and binding of ALG-2 and ALG-2-interacting protein X (ALIX) to the damaged membrane.
    [Show full text]
  • Understanding the Molecular Pathobiology of Acid Ceramidase Deficiency
    Understanding the Molecular Pathobiology of Acid Ceramidase Deficiency By Fabian Yu A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Institute of Medical Science University of Toronto © Copyright by Fabian PS Yu 2018 Understanding the Molecular Pathobiology of Acid Ceramidase Deficiency Fabian Yu Doctor of Philosophy Institute of Medical Science University of Toronto 2018 Abstract Farber disease (FD) is a devastating Lysosomal Storage Disorder (LSD) caused by mutations in ASAH1, resulting in acid ceramidase (ACDase) deficiency. ACDase deficiency manifests along a broad spectrum but in its classical form patients die during early childhood. Due to the scarcity of cases FD has largely been understudied. To circumvent this, our lab previously generated a mouse model that recapitulates FD. In some case reports, patients have shown signs of visceral involvement, retinopathy and respiratory distress that may lead to death. Beyond superficial descriptions in case reports, there have been no in-depth studies performed to address these conditions. To improve the understanding of FD and gain insights for evaluating future therapies, we performed comprehensive studies on the ACDase deficient mouse. In the visual system, we reported presence of progressive uveitis. Further tests revealed cellular infiltration, lipid buildup and extensive retinal pathology. Mice developed retinal dysplasia, impaired retinal response and decreased visual acuity. Within the pulmonary system, lung function tests revealed a decrease in lung compliance. Mice developed chronic lung injury that was contributed by cellular recruitment, and vascular leakage. Additionally, we report impairment to lipid homeostasis in the lungs. ii To understand the liver involvement in FD, we characterized the pathology and performed transcriptome analysis to identify gene and pathway changes.
    [Show full text]
  • Characterization of the Goose CAPN3 Gene and Its Expression Pattern in Muscle Tissues of Sichuan White Geese at Different Growth Stages
    http://www.jstage.jst.go.jp/browse/jpsa doi:10.2141/ jpsa.0170150 Copyright Ⓒ 2018, Japan Poultry Science Association. Characterization of the Goose CAPN3 Gene and its Expression Pattern in Muscle Tissues of Sichuan White Geese at Different Growth Stages Hengyong Xu*, Yahui Zhang*, Quan Zou, Liang Li, Chunchun Han, Hehe Liu, Jiwei Hu, Tao Zhong and Yan Wang Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province, Sichuan Agricultural University, Chengdu 611130, China Calpain 3 (CAPN3), also known as p94, is associated with multiple production traits in domestic animals. However, the molecular characteristics of the CAPN3 gene and its expression profile in goose tissues have not been reported. In this study, CAPN3 cDNA of the Sichuan white goose was cloned, sequenced, and characterized. The CAPN3 full-length cDNA sequence consists of a 2,316-bp coding sequence (CDS) that encodes 771 amino acids with a molecular mass of 89,019 kDa. The protein was predicted to have no signal peptide, but several N-glycosylation, O- glycosylation, and phosphorylation sites. The secondary structure of CAPN3 was predicted to be 38.65% α-helical. Sequence alignment showed that CAPN3 of Sichuan white goose shared more than 90% amino acid sequence similarity with those of Japanese quail, turkey, helmeted guineafowl, duck, pigeon, and chicken. Phylogenetic tree analysis showed that goose CAPN3 has a close genetic relationship and small evolutionary distance with those of the birds. qRT-PCR analysis showed that in 15-day-old animals, the expression level of CAPN3 was significantly higher in breast muscle than in thigh tissues.
    [Show full text]
  • Supplemental Information IRF4 Transcription Factor-Dependent Cd11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 C
    Immunity, Volume 38 Supplemental Information IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses Andreas Schlitzer, Naomi McGovern, Pearline Teo, Teresa Zelante, Koji Atarashi, Donovan Low, Adrian W.S. Ho, Peter See, Amanda Shin, Pavandip Singh Wasan, Guillaume Hoeffel, Benoit Malleret, Alexander Heiseke, Samantha Chew, Laura Jardine, Harriet A. Purvis, Catharien M.U. Hilkens, John Tam, Michael Poidinger, E. Richard Stanley, Anne B. K rug, Laurent Renia, Baalasubramanian Sivasankar, Lai Guan Ng, Matthew Collin, Paola Ricciardi-Castagnoli, Kenya Honda, Muzlifah Haniffa, and Florent Ginhoux Supplemental Inventory 1. Supplemental Figures and Tables Figure S1, Related to Figure 1 Figure S2, Related to Figure 2 and 3 Figure S3, Related to Figure 4 Figure S4, Related to Figure 5 Figure S5, Related to Figure 5 Figure S6, Related to Figure 7 Table S1, Related to Figure 3 Table S2, Related to Figure 6 Table S3, Related to Figure 6 2. Supplemental Experimental Procedures 3. Supplemental References Supplementary figure 1 Sorting strategy for mouse lung and small intestinal DC A Sorting strategy, Lung Singlets Dapi-CD45+ 250K 250K 250K 105 200K 200K 200K 104 A I - 150K 150K 150K C P C C 3 10 S A S S 100K 100K S 100K D S S 102 50K 50K 50K 0 0 0 0 0 50K 100K 150K 200K 250K 0 50K 100K 150K 200K 250K 0 103 104 105 0 103 104 105 FSC FSC-W CD45 GR1 Auto Fluor.- MHCII+ GR1- SSClow CD11c+ CD11b+ 250K 105 105 105 200K 4 104 10 104 150K I 3 I 3 4 3 0 10 3 C 2 H 10 10 100K 1 S D C D S C M 2 C 10 50K 0 0 0 0 0 102 103 104 105 0 103 104 105 0 103 104 105 0 103 104 105 Auto fluor.
    [Show full text]
  • CRAVAT 4: Cancer-Related Analysis of Variants Toolkit David L
    Cancer Focus on Computer Resources Research CRAVAT 4: Cancer-Related Analysis of Variants Toolkit David L. Masica1,2, Christopher Douville1,2, Collin Tokheim1,2, Rohit Bhattacharya2,3, RyangGuk Kim4, Kyle Moad4, Michael C. Ryan4, and Rachel Karchin1,2,5 Abstract Cancer sequencing studies are increasingly comprehensive and level interpretation, including joint prioritization of all nonsilent well powered, returning long lists of somatic mutations that can be mutation consequence types, and structural and mechanistic visu- difficult to sort and interpret. Diligent analysis and quality control alization. Results from CRAVAT submissions are explored in an can require multiple computational tools of distinct utility and interactive, user-friendly web environment with dynamic filtering producing disparate output, creating additional challenges for the and sorting designed to highlight the most informative mutations, investigator. The Cancer-Related Analysis of Variants Toolkit (CRA- even in the context of very large studies. CRAVAT can be run on a VAT) is an evolving suite of informatics tools for mutation inter- public web portal, in the cloud, or downloaded for local use, and is pretation that includes mutation mapping and quality control, easily integrated with other methods for cancer omics analysis. impact prediction and extensive annotation, gene- and mutation- Cancer Res; 77(21); e35–38. Ó2017 AACR. Background quickly returning mutation interpretations in an interactive and user-friendly web environment for sorting, visualizing, and An investigator's work is far from over when results are returned inferring mechanism. CRAVAT (see Supplementary Video) is from the sequencing center. Depending on the service, genetic suitable for large studies (e.g., full-exome and large cohorts) mutation calls can require additional mapping to include all and small studies (e.g., gene panel or single patient), performs relevant RNA transcripts or correct protein sequences.
    [Show full text]
  • Apoptosis and Differentiation Commitment: Novel Insights Revealed by Gene Profiling Studies in Mouse Embryonic Stem Cells
    Cell Death and Differentiation (2006) 13, 564–575 & 2006 Nature Publishing Group All rights reserved 1350-9047/06 $30.00 www.nature.com/cdd Apoptosis and differentiation commitment: novel insights revealed by gene profiling studies in mouse embryonic stem cells D Duval1,2,4, M Trouillas3,4, C Thibault2, D Dembele´ 2, Introduction F Diemunsch2, B Reinhardt2, AL Mertz2, A Dierich2 Mouse embryonic stem (ES) cells, which are maintained and H Bœuf*,3 pluripotent in vitro with leukemia inhibitory factor (LIF) cytokine, are instrumental to study LIF-dependent cell 1 UMR5096-CNRS/UP/IRD, Perpignan, France 2 IGBMC/CNRS/INSERM, Strasbourg, France pluripotency as well as the first steps of differentiation 3 UMR-5164-CNRS-CIRID/Universite´ Bordeaux2, Bordeaux, France commitment triggered upon LIF starvation. As we recently 4 These authors contributed equally to this work reported, these cells could also be used to unravel the early * Corresponding author: H Bœuf, UMR-5164-CNRS-CIRID, Universite´ steps of apoptosis, a physiological cell death process Bordeaux2, Bat.1B, BP14, 146 rue Le´o Saignat, 33076 Bordeaux, France. occurring during the first embryogenesis stages. Indeed, the Tel: þ 05 57 57 46 33; Fax: þ 05 57 57 14 72; formation of the cavities, which starts at the blastocyst stage, E-mail:helene.bœ[email protected] is dependent on a specific cell death program, which includes caspase 3 cleavage and induction of the apoptosis-inducing Received 10.3.05; revised 01.9.05; accepted 01.9.05; published online 25.11.05 1 Edited by R De Maria factor (AIF)-complex proteins.
    [Show full text]
  • A Human Population-Based Organotypic in Vitro Model for Cardiotoxicity Screening1
    ALTEX preprint published July 8, 2018 doi:10.14573/altex.1805301 Research Article A human population-based organotypic in vitro model for cardiotoxicity screening1 Fabian A. Grimm1, Alexander Blanchette1, John S. House2, Kyle Ferguson1, Nan-Hung Hsieh1, Chimeddulam Dalaijamts1, Alec A. Wright1, Blake Anson5, Fred A. Wright3,4, Weihsueh A. Chiu1, Ivan Rusyn1 1Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA; 2Bioinformatics Research Center, 3Department of Biological Sciences, and 4Department of Statistics, North Carolina State University, Raleigh, NC, USA; 5Cellular Dynamics International, Madison, WI, USA Abstract Assessing inter-individual variability in responses to xenobiotics remains a substantial challenge, both in drug development with respect to pharmaceuticals and in public health with respect to environmental chemicals. Although approaches exist to characterize pharmacokinetic variability, there are no methods to routinely address pharmacodynamic variability. In this study, we aimed to demonstrate the feasibility of characterizing inter-individual variability in a human in vitro model. Specifically, we hypothesized that genetic variability across a population of iPSC- derived cardiomyocytes translates into reproducible variability in both baseline phenotypes and drug responses. We measured baseline and drug-related effects in iPSC-derived cardiomyocytes from 27 healthy donors on kinetic Ca2+ flux and high-content live cell imaging. Cells were treated in concentration-response with cardiotoxic drugs: isoproterenol (β- adrenergic receptor agonist/positive inotrope), propranolol (β-adrenergic receptor antagonist/negative inotrope), and cisapride (hERG channel inhibitor/QT prolongation). Cells from four of the 27 donors were further evaluated in terms of baseline and treatment-related gene expression. Reproducibility of phenotypic responses was evaluated across batches and time.
    [Show full text]